News

Home > Viva Biotech and AlphaMa Reached Cooperation Agreement on IntelligentDEL (iDEL)

Viva Biotech and AlphaMa Reached Cooperation Agreement on IntelligentDEL (iDEL)

Publication time: 2020-12-22 Article source: Shanghai

SHANGHAI, CHINA----Recently, Viva Biotech signed a new drug discovery technology cooperation agreement with AlphaMa Biotech Co., Ltd. (hereinafter referred to as "AlphaMa"). According to the agreement, Viva Biotech will cooperate with AlphaMa on innovative drug discovery technology to provide clients with the new generation of AI-based DNA coding compound library (Intelligent DEL, iDEL) screening technology platform for screening tumors and lead compounds for a series of specific targets in the field of neurological, autoimmune and other diseases.